作者: Wilson Gonsalves , Apar Kishor Ganti
DOI: 10.1016/J.CRITREVONC.2010.06.001
关键词:
摘要: Cancer is a disease of the elderly with majority new diagnoses and deaths from cancer occurring in persons greater than 65 years age. A major goal therapy, preservation functional independence quality life. The advent targeted therapies has raised hope that older patients could be treated as effectively younger without added toxicities. However, caution must exercised while addressing use these population only after taking into consideration risks, benefits prognosis on an individual basis. This article reviews current literature efficacy, cost-effectiveness toxicity currently approved agents population.